FGF23 Affects the Lineage Fate Determination of Mesenchymal Stem Cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Calcified Tissue International

• Publication date

  2013-09-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00223-013-9795-6PMID 24068282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate

  2013cited by this paper
• Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.

  2012cited by this paper
• FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble α-Klotho both in Vitro and in Vivo*

  2012cited by this paper
• Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization

  2011cited by this paper
• Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

  2011cited by this paper
• Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

  2011cited by this paper
• Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: A possible cause for reduced osteogenesis and increased adipogenesis in older individuals

  2011cited by this paper
• Serum fibroblast growth factor‐23 (FGF‐23) and fracture risk in elderly men

  2011cited by this paper
• FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.

  2010cited by this paper
• Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

  2010cited by this paper
• The Amazing Osteocyte

  2010cited by this paper
• Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.

  2009cited by this paper
• FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling.

  2009cited by this paper
• Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

  2009cited by this paper
• Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men

  2009cited by this paper
• Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

  2009cited by this paper
• Relationship between circulating FGF23 and total body atherosclerosis in the community.

  2009cited by this paper
• Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

  2008cited by this paper
• Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen.

  2008cited by this paper
• Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

  2008cited by this paper
• Actions and mode of actions of FGF19 subfamily members.

  2008cited by this paper
• Amelioration of the premature ageing‐like features of Fgf‐23 knockout mice by genetically restoring the systemic actions of FGF‐23

  2008cited by this paper
• Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

  2008cited by this paper
• The parathyroid is a target organ for FGF23 in rats.

  2007cited by this paper
• Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

  2007cited by this paper
• Mineralized tissue cells are a principal source of FGF23.

  2007cited by this paper
• Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

  2007cited by this paper
• Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals.

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling*

  2005cited by this paper
• Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins*

  2005cited by this paper
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice.

  2004cited by this paper
• Distinct osteogenic mechanisms of bones of distinct origins

  2004cited by this paper
• Modulation of Adherence and Chemotaxis of Macrophages by Norepinephrine. Influence of Ageing

  2004cited by this paper
• Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis

  2004cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Cranial skeletal biology

  2003cited by this paper
• Mechanisms balancing skeletal matrix synthesis and degradation.

  2002cited by this paper
• Mediation of Unusually High Concentrations of 1,25-Dihydroxyvitamin D in Homozygous klotho Mutant Mice by Increased Expression of Renal 1α-Hydroxylase Gene.

  2002cited by this paper
• Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene.

  2002cited by this paper
• Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis.

  2000cited by this paper
• Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation

  1999cited by this paper
• Mutation of the mouse klotho gene leads to a syndrome resembling ageing

  1997cited by this paper
• Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

  1997cited by this paper
• Quantitative comparisons of healing in cranial fresh autografts, frozen autografts and processed autografts, and allografts in canine skull defects.

  1986cited by this paper
• Preparation and Characterization of Human Bone Marrow‐Derived Macrophages

  1985cited by this paper
• Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies.

  1971cited by this paper

• Site-specific inverse associations between FGF23 levels and marrow adiposity content at the proximal femur in post-menopausal women.

  2026cites this paper
• Exploring the Role of Hormones and Cytokines in Osteoporosis Development

  2024cites this paper
• Distinct role of Klotho in long bone and craniofacial bone: skeletal development, repair and regeneration

  2024cites this paper
• Non-Classical Effects of FGF23: Molecular and Clinical Features

  2024cites this paper
• Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney

  2023cites this paper
• Relationship between bone marrow adipose tissue and kidney function in postmenopausal women

  2023cites this paper
• To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors.

  2023cites this paper
• Engineered Cell‐Laden Armor Unit‐Mimicking Bioceramic Granules for Bone Regeneration

  2023cites this paper
• Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells

  2022cites this paper
• Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients

  2022cites this paper
• Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside

  2022cites this paper
• Fibroblast growth factor (FGF) and FGF receptor families in bone

  2020cites this paper
• Fibroblast growth factor 23 counters vitamin D metabolism and action in human mesenchymal stem cells.

  2020cites this paper
• microRNA‐199a counteracts glucocorticoid inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro

  2020cites this paper
• FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation

  2019cites this paper
• Healing of osteoporotic bone defects by micro-/nano-structured calcium phosphate bioceramics.

  2019cites this paper
• FGF23 Actions on Target Tissues—With and Without Klotho

  2018cites this paper
• Chronic kidney disease and vitamin D metabolism in human bone marrow–derived MSCs

  2017cites this paper
• Bone regeneration with micro/nano hybrid-structured biphasic calcium phosphate bioceramics at segmental bone defect and the induced immunoregulation of MSCs.

  2017cites this paper
• Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate

  2017cites this paper
• Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow‐derived mesenchymal stem cells

  2017cites this paper
• Effect of Fibroblast Growth Factor 23 on Osteoblastic Differentiation and Mineralization of D1 Mesenchymal Stem Cells

  2016influential citation
• Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.

  2016cites this paper
• Expression of osteoclastogenic factor transcripts in osteoblast‐like UMR‐106 cells after exposure to FGF‐23 or FGF‐23 combined with parathyroid hormone

  2016influential citation
• Avaliação de células-tronco mesenquimais do cordão umbilical humano em lesão de órgãos e disfunção endotelial na sepse

  2015cites this paper
• Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway

  2015cites this paper
• Myogenic-specific ablation of Fgfr1 impairs FGF2-mediated proliferation of satellite cells at the myofiber niche but does not abolish the capacity for muscle regeneration

  2015cites this paper
• New insights into the FGF23-Klotho axis.

  2014cites this paper
• Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: The role of fibroblast growth factor 23

  2014cites this paper
• Impact of senescence on bone quality: lessons from animal models of aging

  2014cites this paper
• New Insights Into the FGF 23-Klotho Axis

  2014cites this paper
• Senomorphic, senolytic, and rejuvenation therapies

  year unknowncites this paper